Nimenrix is indicated for active immunisation of individuals from the age of 6 weeks
Nimenrix is indicated for active immunisation of individuals from the age of 6 weeks against invasive meningococcal disease caused by Neisseria meningitidis groups A, C, W-135, and Y
Related products